StockIQpro
NASDAQ:INVA

Innoviva, Inc.

Innoviva, Inc.'s revenue grew 14.7% in fiscal 2025 to $411.3M while operating margin fell to 39.8%. Free cash flow was $195.8M, 47.6% of revenue, and the diluted share count rose 14.3%.Summary generated from Innoviva, Inc.'s SEC filings. Latest annual report filed Feb 25, 2026.

Revenue (FY25)$411.3M
Revenue growth+14.7%
Revenue, 5-yr CAGR+4.1%
Gross margin74.8%
Operating margin39.8%
Net margin65.9%
ROIC17.8%
Return on equity29.1%
Debt / equity0.22
Free cash flow$195.8M
FCF margin47.6%
Share count change+14.3%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue392331310359411
Operating income375n/a114167164
Net income36922018023271
Free cash flow364202141188196

Recent filings

From SEC EDGAR

Peers

Pharmaceutical preparations